Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VPT:CC - Ventripoint Diagnostics Announces Shareholder Update and Teleconference


VPT:CC - Ventripoint Diagnostics Announces Shareholder Update and Teleconference

(TheNewswire)

Toronto, Ontario – TheNewswire –June 11, 2024 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT; OTC:VPTDF)announced a teleconference to be conducted June 14 th at which anupdate to shareholders will be provided.

“During the first quarter we focused on effectingleadership change in the company and assessing the status of thetechnology, user base, operations and commercialisation. TheVentripoint team worked closely with our EU and UK distributors toimprove sales and customer support processes and decided againstrenewing agreements with non-performing US distributors.  Weeffectively controlled our operating expenses and updated internalplans and forecasts to identify capital requirements for 2024. TheCompany is now in the process of implementing CRM and new projectmanagement software and is adopting a product management discipline.These changes are positioning Ventripoint to become better alignedwith patient and clinician needs and to support revenue generation andgrowth” said Hugh MacNaught, Ventripoint President & CEO.

“We remain committed to enhancing the level of careprovided to the 13 million worldwide sufferers of congenital heartdefects with affordable, accurate and reliable measurements of heartstructure and function and intend to establish market leadership by2025. Concurrently the Company is actively identifying additionalclinical indications and market segments in which VMS+ offers a clearvalue proposition.”

Highlights include:

  • Sale of a second unit to Duke UniversityHospital

  • Migration of the corporate website to a newplatform

  • Sponsorship of the AEPC conference in Porto, Portugaland delivery of two hands-on workshops with VMS+

  • Submission of VMS+ V4.0 to FDA for 510(k)clearance

  • Recruitment of two members to the marketingteam

  • Annual MDSAP audit

  • Regulatory approval of VMS+ in New Zealand

  • Selection of a regulatory consultant forBrazil

  • Initiation of financing of up to $3M CAD throughconvertible debentures

In other news, the Company’sfinancial results for the first quarter ended March 31, 2024, and therelated MD&A, have been filed and are available on the System forElectronic Document Analysis and Retrieval (SEDAR+) atwww.sedarplus.ca.

The Company wishes to invite its shareholders to ateleconference to be held on Friday, June 14, 2024, at 11:00 am EST.

•        Participants can access the call bydialing 1-844-763-8274 or +1-647-484-8814. It is recommended that youcall 10 minutes before the scheduled start time to avoid thequeue.

•        After the call, an audio recording willbe made available via telephone for one month, until end of day July14th. The recording can be accessed by dialing 1-855-669-9658 or+1-604-674-8052 and using the access code 0828#.

•        A written transcript of the call will beavailable on Ventripoint’s website shortly after its conclusion. For further information,please contact:

Jonathan Robinson

JRobinson@oakhillfinancial.ca

416-669-1001

Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.

Forward Looking Statements

This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Company.Although the Company believes that the expectations and assumptions onwhich such forward-looking statements and information are based arereasonable, undue reliance should not be placed on the forward-lookingstatements and information because the Company can give no assurancethat they will prove to be correct.

Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws

Copyright (c) 2024 TheNewswire - All rights reserved.

Stock Information

Company Name: Ventripoint Diagnostics Ltd.
Stock Symbol: VPT:CC
Market: TSXVC
Website: ventripoint.com

Menu

VPT:CC VPT:CC Quote VPT:CC Short VPT:CC News VPT:CC Articles VPT:CC Message Board
Get VPT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...